This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

About the Neuropharmacology Affinity Group

The Neuropharmacology Affinity Group serves members with interests in all areas of neuroscience, neuropharmacology and neurotoxicology in health and disease including both experimental and clinical aspects from the molecular level, through cellular and systems to behavioural aspects. This includes, but is not limited to: molecular and cellular studies on brain cells or cells involved in supporting the nervous system; studies of the autonomic, peripheral and  central nervous systems and the use and abuse of drugs influencing neuronal function at the molecular, cellular, systems or behavioural levels.

Sign up to the Neuropharmacology Affinity Group through the 'Committees & Groups' tab on the 'Update my profile' page.

Contact the Co-Chairs

Email the Co-Chairs at:​


Mark Tricklebank

Clare Stanford